.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
McKinsey
Boehringer Ingelheim
Moodys
Accenture
Dow
Chinese Patent Office
Fish and Richardson
Johnson and Johnson
Fuji

Generated: September 19, 2017

DrugPatentWatch Database Preview

Iofetamine hydrochloride i-123 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iofetamine hydrochloride i-123 and what is the scope of iofetamine hydrochloride i-123 freedom to operate?

Iofetamine hydrochloride i-123
is the generic ingredient in one branded drug marketed by IMP and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: iofetamine hydrochloride i-123

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list23
Clinical Trials: see list2,376
Patent Applications: see list1
Drug Prices:see low prices
DailyMed Link:iofetamine hydrochloride i-123 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Imp
SPECTAMINE
iofetamine hydrochloride i-123
INJECTABLE;INJECTION019432-001Dec 24, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: iofetamine hydrochloride i-123

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Imp
SPECTAMINE
iofetamine hydrochloride i-123
INJECTABLE;INJECTION019432-001Dec 24, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
UBS
McKesson
Harvard Business School
Cantor Fitzgerald
Johnson and Johnson
Baxter
Chinese Patent Office
US Department of Justice
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot